GC Genome said Thursday that it has launched the “Hair Loss Risk Screen” test, which can check the risk of genetic development by hair loss type by selecting genes related to hair loss.The company’s latest product identifies genetic factors that may affect male and female alopecia and alopecia areat
TiumBio said on Tuesday that it received a $4.5 million upfront payment from China’s Hansoh Pharmaceutical under the previous licensing agreement involving TU2670, a new endometriosis treatment.Earlier in August, TiumBio and Hansoh signed a $170 million deal, including a $4.5 million upfront payment
Mirae Asset Venture Investment and Yuanta Investment have been selected as the management companies of the 500 billion won ($347 million) “K-Bio Vaccine Fund.”The Ministry of Health and Welfare and Korea Venture Investment Corp. (KVIC) on Wednesday announced their final selection of Mirae Asset Vent
Samsung Bioepis said Tuesday that it would present three scientific abstracts for its ophthalmology biosimilars at the American Academy of Ophthalmology (AAO) 2022 from Sept. 30 to Oct. 3 in the U.S.The company conducted phase 3 studies to compare the efficacy, safety, immunogenicity, and pharmacoki
Researchers from Seoul National University College of Medicine (SNUCM) found that frequently consuming small amounts of alcohol increased the risk of developing gastric cancer.The study, led by Professor Kang Dae-hee, investigated 128,218 healthy middle-aged Korean adults aged 40 to 69 who participa
Celltrion said Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab) to treat various cancers.The approval in Japan follows Celltrion obtaining marketing approval for Vegzelma from the European Commission (EC) in Augus
The International Vaccine Institute (IVI) is hosting its 21st international five-day vaccinology course at the SNU Faculty House Convention Center which will run through Friday this week.IVI's Director General, Dr. Jerome Kim, said the trainees had to focus on moving vaccines from “need” to “impact”
A team of researchers at Seoul National University Bundang Hospital said they discovered that a thinner retinal nerve fiber layer (RNFL) was associated with a higher risk of cognitive impairment in a large cohort study.It is the first time in Korea that a local study identified the relationship betw
Researchers of the Urology Department at Asan Medical Center (AMC) said they have discovered a way to improve symptoms caused by interstitial cystitis or bladder pain syndrome by administering mesenchymal stem cells derived from human embryonic stem cells.Interstitial cystitis, which is accompanied
A Pakistani professor from a Swiss university said consanguineous marriages were the best resource to study recessive disorders because it is easier to identify new genes in this population.Muhammad Ansar from the University of Lausanne presented on the discovery of new recessive disease genes and t
A team of researchers at Yonsei Severance Hospital said they discovered six key cardiovascular health (CVH) metrics to reduce dementia risk in a recent study.According to the World Health Organization (WHO), dementia is the deterioration in cognitive function which affects memory, thinking, orientat
A joint research team from Korea Advanced Institute of Science and Technology (KAIST) said on Wednesday they developed a bio-friendly adhesive by mixing tannic acid with bio-compatible polymers to improve existing hair transplant methods.Tannic acid is a type of polyphenol found in fruit shells, nut
The bio-medical industry, which was the largest investment destination for venture capital (VC) companies from 2018 to 2020, slumped to third place in the first half of this year.According to a report by the Biotech Policy Research Center, new VC investment in the bio-medical industry was 675.8 bill
ABL Bio will receive a short-term milestone of $20 million (27.8 billion won) from Sanofi.ABL Bio said in a public notice last Thursday that it would get $20 million in technical fees from Sanofi. The company explained that it was a milestone upon the completion of the non-clinical toxicity test (GL
Celltrion said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab), to treat various cancers.The company received full label approval for all of Avastin's indications, including metastatic colore
Prestige BioPharma said Thursday it has voluntarily withdrawn its European Medicines Agency (EMA) application for the re-examination of approving HD201 (brand name: Tuznue), a biosimilar referencing Herceptin to treat breast cancer and metastatic gastric cancer.The withdrawal comes after the company
Voronoi and U.S. bio company METiS Therapeutic have signed a contract to license out (L/O) kinase inhibitor technology worth 668 billion won ($482 million).In a public notice Wednesday, Voronoi said it had signed a technology transfer contract for phosphorylase inhibitors for oral use (kinase) for t
HLB, a Korean biotech firm, said Tuesday it would submit a new drug application (NDA) to the FDA for marketing approval of an anticancer drug, rivoceranib, in early 2023.HLB said the FDA’s designation of camrelizumab, used in combination with rivoceranib, as an orphan drug would speed up the regulat
The U.S. Food and Drug Administration recommended Golden Biotechnology Corp., a Taiwanese biopharmaceutical company, to conduct an additional clinical trial of antroquinonol, a Covid-19 treatment candidate, BNC Korea said.In August 2020, Golden Biotech and BNC Korea signed an agreement for the latte
U.S. President Joe Biden on Monday signed an executive order implementing a new initiative aiming to boost biomanufacturing in pharmaceuticals.The initiative aims to help expand U.S. biomanufacturing capabilities and reduce reliance on China.According to people familiar with the matter, the order la